Remibrutinib Shows Promise for Chronic Hives Relief
Chronic spontaneous urticaria, defined by recurring hives, itching, or skin swelling lasting more than 6 weeks, affects about 3 million people in the US. The causes of the syndrome are unknown, and roughly half of patients continue to have symptoms after first-line treatment with second-generation H1 antihistamines.
Chronic spontaneous urticaria, defined by recurring hives, itching, or skin swelling lasting more than 6 weeks, affects about 3 million people in the US. The causes of the syndrome are unknown, and roughly half of patients continue to have symptoms after first-line treatment with second-generation H1 antihistamines.